Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 5Papillomavirus Infections 5Ovarian Neoplasms 4Neoplastic Cells, Circulating 4Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Lung Neoplasms 3Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Thymic aplasia 1Stomach Neoplasms 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Respiratory Distress Syndrome 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Osteosarcoma 1Opioid-Related Disorders 1

Interventions

salicylhydroxamic acid 1X-Rays 1Sublocade 1Standard of Care 1Radiography, Abdominal 1Morphine 1Methadone 1Hematologic Tests 1Buprenorphine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Opioid-Related Disorders × Blood Specimen Collection × Clear all
NCT05251376 2023-01-19

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Lyndra Inc.

Phase 1 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡